| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |